Remove 2022 Remove Leads Remove Pharma
article thumbnail

LTS Lohmann leads investment in needle-free delivery specialist

Fierce Pharma

LTS Lohmann leads investment in needle-free delivery specialist. Tue, 11/29/2022 - 10:21.

Leads 263
article thumbnail

Erytech pivots to extracellular vesicle drug delivery after lead candidate collapses

Fierce Pharma

Erytech pivots to extracellular vesicle drug delivery after lead candidate collapses. Tue, 11/22/2022 - 08:53.

Leads 235
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A realistic view of healthcare in 2022

World of DTC Marketing

3hree: Pharma will increase its spending in digital, but a lot of the money will be wasted. Studies show that tens of millions of dollars are being wasted due to fraud with programmatic advertising, but many pharma companies are still wasting money on the channel. The post A realistic view of healthcare in 2022.

article thumbnail

Pharma running online ads on vaccine misinformation sites

World of DTC Marketing

Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. When will pharma stop using programmatic online ads? Again and again, I have seen robust fraud and online ads being placed on sites that pharma would normally block in their system. Programmatic has been a thorn in online advertisers.

Pharma 180
article thumbnail

2022 Predictions From the Front-Lines of Pharma Digital Advertising

Pharma Marketing Network

The pharma industry has been slower to embrace digital technologies than other less-regulated sectors but the COVID-19 pandemic has greatly changed this long-standing mindset. In 2020 and 2021, we saw pharma forced to become more flexible and open-minded than ever before. In this article, R.J. COVID is Likely Here to Stay.

Pharma 105
article thumbnail

Big Pharma leading in access-to-medicine strategies, shows data

European Pharmaceutical Review

Bayer joined the top ten for the first time, with the broad geographic reach of its R&D plans highlighted as a best practice in the 2022 Index. 2022 Access to Medicine Index findings. The post Big Pharma leading in access-to-medicine strategies, shows data appeared first on European Pharmaceutical Review.

article thumbnail

PHARMA BRAND PLANNING IN 2022: CONSIDER THESE 3 FACTORS

eMediWrite

Every year, pharma marketing teams engage in multi-phased, cross-functional, multi-organizational strategic planning and also in aligning work-stream dubbed “Brand Planning” by many in the industry. From a general perspective, despite large gains in site traffic (+16%), pharma website engagement rates were down.

Pharma 98